GLP1R and inflammatory bowel disease: Several large-scale observational studies have further highlighted potential reductions in the need for intestinal resections and IBD disease-related complications among GLP-1 users, particularly in ulcerative colitis patients with elevated body mass index or metabolic comorbidities (7, 15–19).